Correlation Between PTC Therapeutics and Travere Therapeutics
Can any of the company-specific risk be diversified away by investing in both PTC Therapeutics and Travere Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PTC Therapeutics and Travere Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PTC Therapeutics and Travere Therapeutics, you can compare the effects of market volatilities on PTC Therapeutics and Travere Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PTC Therapeutics with a short position of Travere Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of PTC Therapeutics and Travere Therapeutics.
Diversification Opportunities for PTC Therapeutics and Travere Therapeutics
0.83 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between PTC and Travere is 0.83. Overlapping area represents the amount of risk that can be diversified away by holding PTC Therapeutics and Travere Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Travere Therapeutics and PTC Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PTC Therapeutics are associated (or correlated) with Travere Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Travere Therapeutics has no effect on the direction of PTC Therapeutics i.e., PTC Therapeutics and Travere Therapeutics go up and down completely randomly.
Pair Corralation between PTC Therapeutics and Travere Therapeutics
Given the investment horizon of 90 days PTC Therapeutics is expected to generate 0.93 times more return on investment than Travere Therapeutics. However, PTC Therapeutics is 1.07 times less risky than Travere Therapeutics. It trades about 0.13 of its potential returns per unit of risk. Travere Therapeutics is currently generating about 0.11 per unit of risk. If you would invest 4,047 in PTC Therapeutics on September 2, 2024 and sell it today you would earn a total of 341.00 from holding PTC Therapeutics or generate 8.43% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
PTC Therapeutics vs. Travere Therapeutics
Performance |
| Timeline |
| PTC Therapeutics |
| Travere Therapeutics |
PTC Therapeutics and Travere Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with PTC Therapeutics and Travere Therapeutics
The main advantage of trading using opposite PTC Therapeutics and Travere Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PTC Therapeutics position performs unexpectedly, Travere Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Travere Therapeutics will offset losses from the drop in Travere Therapeutics' long position.| PTC Therapeutics vs. Krystal Biotech | PTC Therapeutics vs. Sarepta Therapeutics | PTC Therapeutics vs. Iovance Biotherapeutics | PTC Therapeutics vs. Madrigal Pharmaceuticals |
| Travere Therapeutics vs. Tff Pharmaceuticals | Travere Therapeutics vs. Eliem Therapeutics | Travere Therapeutics vs. Inhibrx | Travere Therapeutics vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |